Skip to main content

Prostate Cancer Clinical Trials

Review the prostate cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 276-300 of 524

Image-Guidance and Online Adaptation with Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Computed Tomography-Guided Stereotactic Body Radiation Therapy with Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Two-Fraction High Dose Rate Brachytherapy Delivered Three Hours Apart for Localized Prostate Cancer
Status: Active
Location: University of California San Francisco, San Francisco, California
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
Status: Active
Location: See ClinicalTrials.gov
ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer
Status: Active
Location: See ClinicalTrials.gov
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Status: Active
Location: University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
Status: Active
Location: See ClinicalTrials.gov
Evaluation of AP-002 in Patients With Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
ALG.APV-527 First-in-human Study
Status: Active
Location: See ClinicalTrials.gov
Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
Status: Active
Location: UF Health Cancer Institute - Gainesville, Gainesville, Florida
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Status: Active
Location: See ClinicalTrials.gov
A Study Evaluating MM-310 in Patients With Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
PM14 Administered Intravenously to Patients with Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
Total Eradication following Radiation for the Treatment of Oligometastatic Prostate Cancer, TERPS Study
Status: Enrolling by Invitation
Location: 10 locations
Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol
Status: Enrolling by Invitation
Location: See ClinicalTrials.gov
Abiraterone and Prednisone with Standard ADT versus Standard ADT Alone in Treating Prostate Cancer Patients
Status: Approved
Location: University of Nebraska Medical Center, Omaha, Nebraska
PSMA-PET Guided De-escalated Radiation Therapy for the Treatment of Recurrent Prostate Cancer after Radical Prostatectomy
Status: Approved
Location: University of Nebraska Medical Center, Omaha, Nebraska
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
Status: Temporarily Closed to Accrual
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Robot-Assisted Radical Prostatectomy with or without Vesicopexy in Patients with Prostate Cancer
Status: Temporarily Closed to Accrual
Location: 2 locations
Evaluation of Erectile and Urinary Function following Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft for Patients with Localized Prostate Cancer, AMNIOX CORD Study
Status: Temporarily Closed to Accrual
Location: Hackensack University Medical Center, Hackensack, New Jersey
Surgical Removal of Prostate Tumor and Antiandrogen Therapy with or without Docetaxel in Treating Men with Newly Diagnosed Metastatic Prostate Cancer
Status: Temporarily Closed to Accrual
Location: 18 locations
Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer
Status: Temporarily Closed to Accrual
Location: 2 locations
Hypofractionated Proton Beam Radiation Therapy in Treating Patients with Localized Prostate Cancer
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Vidutolimod (CMP-001) in Combination with Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
Status: Temporarily Closed to Accrual
Location: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
177Lu-PSMA-617 for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with Bone Marrow Involvement and Cytopenia
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas